The update of prostatic ductal adenocarcinoma

被引：0

作者：

Tantan Liu ^{[1
]}

Yingmei Wang ^{[1
]}

Ru Zhou ^{[1
]}

Haiyang Li ^{[1
,2
]}

Hong Cheng ^{[1
]}

Jing Zhang ^{[1
]}

机构：

[1] State Key Laboratory of Tumor Biology, Department of Pathology, Xijing Hospital

[2] Cadet Brigade, The Fourth Military Medical University

来源：

ChineseJournalofCancerResearch | 2016年 / 28卷 / 01期

基金：

中国国家自然科学基金;

关键词：

Prostatic cancer; ductal adenocarcinoma; clinicopathology; differential diagnosis;

D O I：

暂无

中图分类号：

R737.25 [前列腺肿瘤];

学科分类号：

100214 ;

摘要：

Since initially described in 1967, prostatic ductal adenocarcinoma(PDA) has engendered a series of controversies on its origin, histological features, and biological behavior. Owing to the improvement of molecular biological technique, there are some updated findings on the characteristics of PDA. In the current review, we will mainly analyze its origin, clinical manifestations, morphological features, differential diagnosis, immunophenotype and molecular genetics, with the purpose of enhancing recognition of this tumor and making a correct diagnosis and treatment choice.

引用

页码：50 / 57

页数：8

共 21 条

[1] Ductal adenocarcinoma of the prostate: a Hong Kong case series[J] . Raymond Wai Man Kan,Chi Fai Kan,Joseph Hon Ming Wong,Kenneth Kam Fung Fu,Chi Fai Ng,Steve Wai Hee Chan.International Urology and Nephrology . 2014 (11)
[2] Immunohistochemical profile of ductal adenocarcinoma of the prostate
Seipel, Amanda H.
Samaratunga, Hemamali
Delahunt, Brett
Wiklund, Fredrik
Wiklund, Peter
Lindberg, Johan
Gronberg, Henrik
Egevad, Lars
[J]. VIRCHOWS ARCHIV, 2014, 465 (05) : 559 - 565
[3] Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists[J] . Amanda H Seipel,Brett Delahunt,Hemamali Samaratunga,Mahul Amin,Joel Barton,Daniel M Berney,Athanase Billis,Liang Cheng,Eva Comperat,Andrew Evans,Samson W Fine,David Grignon,Peter A Humphrey,Cristina Magi‐Galluzzi,Rodolfo Montironi,Isabell Sesterhenn,John R Srigley,Kiril Trpkov,Theo Kwast,Murali Varma,Ming Zhou,Amar Ahmad,Sue Moss,Lars Egevad.Histopathology . 2014 (2)
[4] Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens[J] . Amanda H. Seipel,Fredrik Wiklund,N Peter Wiklund,Lars Egevad.Virchows Archiv . 2013 (4)
[5] Prostate Cancer Stem Cells
Tu, Shi-Ming
Lin, Sue-Hwa
[J]. CLINICAL GENITOURINARY CANCER, 2012, 10 (02) : 69 - 76
[6] Immunohistochemical verification of ductal differentiation in prostate cancer
Tarjan, Miklos
Lenngren, Anna
Hellberg, Dan
Tot, Tibor
[J]. APMIS, 2012, 120 (06) : 510 - 518
[7] Ductal Adenocarcinoma of the Prostate
Hertel, Johann D.
Humphrey, Peter A.
[J]. JOURNAL OF UROLOGY, 2011, 186 (01) : 277 - 278
[8] Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension
Samaratunga, Hemamali
Duffy, David
Yaxley, John
Delahunt, Brett
[J]. HUMAN PATHOLOGY, 2010, 41 (02) : 281 - 285
[9] Ductal Adenocarcinoma of the Prostate: Increased Mortality Risk and Decreased Serum Prostate Specific Antigen[J] . Todd M. Morgan,Christopher J. Welty,Funda Vakar-Lopez,Daniel W. Lin,Jonathan L. Wright.The Journal of Urology . 2010 (6)
[10] An Update of the Gleason Grading System
Epstein, Jonathan I.
[J]. JOURNAL OF UROLOGY, 2010, 183 (02) : 433 - 440

← 1 2 3 →